healthy humans
Conditions
Interventions
12-wk repeated consumption of control product (product code A-001), visceral fat area measurement every 4wk, pre-treatment observation period (4wk), post-treatment observation period (4wk) , dose of 1
Sponsors
Oriental Ueno Kenshin Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1,25<=BMI<30, 2,visceral fat area=>120cm2, 3,35<=Age<65 of men and postmenopausal women, 4,provides informed consent in a documented form
Exclusion criteria
Exclusion criteria: 1,liver, kidney and heart disease, or disorder of respiration, endocrine, metabolism, nervous system, consciousness, or diabetes, or other diseases, 2,surgery or therapy within 2 months before the trial, 3,medicine user for hyperglycaemia, lipidemia, or hypertension, 4,user of supplements or foods with health claim, 5,unpleasant feeling during blood drawing, 6,donated 200 mL or more blood within 1 month before the trial, 7,changed weight 2 kg or more within 1 month before the trial, 8,shiftworker, 9,plans business trip for 10 consecutive days or more, 10, allergy against any constituents in the test diet, 11, participant in the other trial or plan to be, 12, cannot provide informed consent, 13, judged to be inappropriate as subject by physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visceral fat area | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co. Ltd Sales Department of Regenerative Medicine and Clinical Trials
Outcome results
None listed